Effects of 5-fluorouracil microspheres on cancer in animals
Author Information
Author(s): A Hagiwara, T Takahashi, K Sawai, C Sakakura, H Tsujimoto, T Imanishi, M Ohgaki, J Yamazaki, S Muranishi, A Yamamoto, T Fujita
Primary Institution: Kyoto Prefectural University of Medicine; Kyoto College of Pharmacy
Hypothesis
The new formulation of 5-fluorouracil (5FU) in microspheres will provide better therapeutic effects and lower toxicity compared to the aqueous solution.
Conclusion
The 5FU microspheres significantly improved drug distribution and reduced systemic toxicity while enhancing therapeutic effects in treating peritoneal carcinomatosis in animal models.
Supporting Evidence
- 5FU-MS maintained higher concentrations of the drug in the target area for longer periods.
- The toxicity of 5FU-MS was reduced to less than half that of the aqueous solution.
- Survival times in mice treated with 5FU-MS were significantly longer than those treated with the aqueous solution.
Takeaway
Researchers created a new way to deliver a cancer drug that works better and is less harmful to the body than the old method.
Methodology
The study involved administering 5FU in microspheres to rats and mice, comparing drug distribution, toxicity, and therapeutic effects against an aqueous solution.
Limitations
The study was conducted in animal models, which may not fully represent human responses.
Participant Demographics
Male Wistar rats and BDF1 mice were used in the experiments.
Statistical Information
P-Value
p<0.05
Confidence Interval
95%
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website